Compound information
- Natural Products
- ZC1438906
- Molecular Formula
- C19H28N2O5
- Molecular Weight
- 364.199821996 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2S)-2-(benzyloxycarbonylamino)hexanoyl]amino]-3-methyl-butanoic acid
- InChI
- InChI=1S/C19H28N2O5/c1-4-5-11-15(17(22)21-16(13(2)3)18(23)24)20-19(25)26-12-14-9-7-6-8-10-14/h6-10,13,15-16H,4-5,11-12H2,1-3H3,(H,20,25)(H,21,22)(H,23,24)/t15-,16-/m0/s1
- InChI Key
- SPAQWPZGFYWELB-HOTGVXAUSA-N
- SMILES
- CCCC[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](C(=O)O)C(C)C
- Source
- ZINC000004760610
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 10 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 104.73 Å2 | LogP | 3.152 |
LogS | -3.434 | LogD | 2.496 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.001 |
HIA | 0.849 | F20 % | 0.993 |
F30 % | 0.935 | Caco-2 | -5.461 |
MDCK | -5.321 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.061 | PPB | 86.193 |
VD | 0.275 | Fu | 1.513 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.657 |
CYP2A6 substrate | 0.48 | CYP2B6 substrate | 0.617 |
CYP2C19 inhibitor | 0.118 | CYP2C19 substrate | 0.94 |
CYP2C8 substrate | 0.851 | CYP2C9 inhibitor | 0.175 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.041 |
CYP2D6 substrate | 0.468 | CYP2E1 substrate | 0.305 |
CYP3A4 inhibitor | 0.013 | CYP3A4 substrate | 0.965 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.837 | CL | 2.195 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 0.902 |
Mutagenicity | 0.005 | Rat Oral Acute Toxicity | 0.064 |
FDAMDD | 0.033 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.004 |
Eye Irritation | 0.108 | Respiratory Toxicity | 0.001 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.038 | IGC50 | 2.59 |
LC50FM | 3.702 | LC50DM | 4.612 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.188 | NR-AR-LBD | 0.256 |
NR-AhR | 0.004 | NR-Aromatase | 0.124 |
NR-ER | 0.345 | NR-ER-LBD | 0.334 |
NR-PPAR-gamma | 0.626 | SR-ARE | 0.06 |
SR-ATAD5 | 0.344 | SR-HSE | 0.155 |
SR-MMP | 0.013 | SR-p53 | 0.036 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.